Skip to main content

Iweala Receives $1-Million NIH Grant to Study Alpha-gal Syndrome

June 26, 2020

Onyinye Iweala, MD, PhD, has received a $1-Million NIH Grant to study alpha-gal syndrome. Alpha-gal syndrome is an allergic condition with global reach. Global reports describe patients with delayed allergic reactions to mammalian meat and there is limited understanding of the mechanisms underlying this condition. Iweala’s research explores the role of glycolipids and unconventional T … Continued

Loeser Receives Joseph P. Archie, Jr. Eminent Professorship in Medicine

June 25, 2020

Richard Loeser, Jr., MD, has been named the Joseph P. Archie, Jr. Eminent Professor of Medicine in the division of rheumatology, allergy and immunology. An appointment to a named professorship is one of the highest honors  bestowed on faculty, recognizing scholarly achievement and distinction. Learn more about Dr. Loeser here.  

Iweala, Burks Publish Review of Study About IgE-Producing B Cells in Gut Tissues

May 14, 2020

Onyinye Iweala, MD, PhD, assistant professor in the division of rheumatology, allergy and immunology, and Wesley Burks, MD, Dean of the School of Medicine and CEO of UNC Health, published a review in Nature Reviews Gastroenterology & Hepatology looking at how IgE-producing B cells in the gut expand the gut’s role in food allergy. “Before this study, … Continued

Callahan Explains How To Create A Successful Walking Program in Podcast

May 7, 2020

Leigh Callahan, PhD, discusses the secrets to creating a walking program you will “stick to,” in a new podcast interview with the Arthritis Foundation. The podcast provides specific, practical methods for beginning and maintaining an exercise routine that is designed for each person’s specific physical needs and personal goals. Callahan is the Mary Link Briggs … Continued

Loeser Answers Questions About Osteoarthritis in New Podcast

May 6, 2020

Is osteoarthritis an inevitable part of aging? This is the question Richard Loeser, MD, answers in a new rheumatology podcast interview with, “Joint Action,” sharing insights from the latest research to address common misconceptions regarding osteoarthritis. “The term ‘wear and tear’ was used a lot in the past and it had a negative consequence on … Continued

Gilbert Discusses Gait Speed Study With Rheumatology Consultant

May 5, 2020

Abigail Gilbert, MD, MSCI, was recently interviewed by Rheumatology Consultant discussing pharmacologic and behavioral interventions for the management of knee osteoarthritis, as well as findings from her recent study on gait speed among adults with knee osteoarthritis. Gilbert is assistant professor of medicine in the division of rheumatology, allergy and immunology, specializing in adult and … Continued

CNN Consults Sheikh On the Use of Hydroxychloroquine for Patients with COVID-19

April 8, 2020

Experts say there isn’t sufficient evidence currently to show hydroxychloroquine—used to treat lupus and rheumatoid arthritis—will benefit people affected by the coronavirus. Saira Sheikh, MD, director of the UNC Rheumatology Lupus Clinic and director of the clinical trials program at UNC’s Thurston Arthritis Research Center, told CNN that “hydroxychloroquine may also cause side effects and … Continued

COVID-19 and Autoimmune Disease, Jonas Answers Questions About Medications

April 2, 2020

Beth Jonas, MD, chief of the division of rheumatology, allergy and immunology, was interviewed for an article in Health Central, answering questions about autoimmune disease medications used to treat rheumatoid arthritis that have been shown to increase the risk of certain viral infections. Find the article here.

Sheikh Addresses Media Questions About Lupus Drug Shortages

March 23, 2020

In an interview with UK-based newspaper the “Independent,”  Saira Sheikh, MD, director of the UNC Rheumatology Lupus Clinic and assistant professor of medicine in the division of rheumatology, allergy and immunology, provided clarity regarding chloroquine and hydroxychloroquine. The two medications have been in the news recently, following coverage related to Coronovirus. The result has been … Continued